Previous Article | Next Article 
Molecular and Cellular Biology, June 2000, p. 3977-3987, Vol. 20, No. 11
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Conversion of Topoisomerase I Cleavage Complexes on
the Leading Strand of Ribosomal DNA into 5'-Phosphorylated DNA
Double-Strand Breaks by Replication Runoff
Dirk
Strumberg,1,
André A.
Pilon,1
Melanie
Smith,2
Robert
Hickey,2
Linda
Malkas,2 and
Yves
Pommier1,*
Laboratory of Molecular Pharmacology,
Division of Basic Sciences, National Cancer Institute, National
Institutes of Health, Bethesda, Maryland
20892-4255,1 and Department of
Pharmacology and Experimental Therapeutics, University of Maryland,
Baltimore, Maryland 212012
Received 16 November 1999/Returned for modification 5 January
2000/Accepted 3 March 2000
Topoisomerase I cleavage complexes can be induced by a variety of
DNA damages and by the anticancer drug camptothecin. We have developed
a ligation-mediated PCR (LM-PCR) assay to analyze replication-mediated
DNA double-strand breaks induced by topoisomerase I cleavage complexes
in human colon carcinoma HT29 cells at the nucleotide level. We found
that conversion of topoisomerase I cleavage complexes into
replication-mediated DNA double-strand breaks was only detectable on
the leading strand for DNA synthesis, which suggests an asymmetry in
the way that topoisomerase I cleavage complexes are metabolized on the
two arms of a replication fork. Extension by Taq DNA
polymerase was not required for ligation to the LM-PCR primer,
indicating that the 3' DNA ends are extended by DNA polymerase in vivo
closely to the 5' ends of the topoisomerase I cleavage complexes. These
findings suggest that the replication-mediated DNA double-strand breaks
generated at topoisomerase I cleavage sites are produced by replication
runoff. We also found that the 5' ends of these DNA double-strand
breaks are phosphorylated in vivo, which suggests that a DNA 5' kinase
activity acts on the double-strand ends generated by replication
runoff. The replication-mediated DNA double-strand breaks were rapidly
reversible after cessation of the topoisomerase I cleavage complexes,
suggesting the existence of efficient repair pathways for removal of
topoisomerase I-DNA covalent adducts in ribosomal DNA.
*
Corresponding author. Mailing address: Laboratory of
Molecular Pharmacology, Bldg. 37, Rm. 5D02, NIH, Bethesda, MD
20892-4255. Phone: (301) 496-5944. Fax: (301) 402-0752. E-mail:
pommier{at}nih.gov.

Present address: Department of Internal Medicine (Cancer Research),
West German Cancer Center, University Medical School,
45122 Essen,
Germany.
Molecular and Cellular Biology, June 2000, p. 3977-3987, Vol. 20, No. 11
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Lin, C.-P., Ban, Y., Lyu, Y. L., Liu, L. F.
(2009). Proteasome-dependent Processing of Topoisomerase I-DNA Adducts into DNA Double Strand Breaks at Arrested Replication Forks. J. Biol. Chem.
284: 28084-28092
[Abstract]
[Full Text]
-
Al-Minawi, A. Z., Lee, Y.-F., Hakansson, D., Johansson, F., Lundin, C., Saleh-Gohari, N., Schultz, N., Jenssen, D., Bryant, H. E., Meuth, M., Hinz, J. M., Helleday, T.
(2009). The ERCC1/XPF endonuclease is required for completion of homologous recombination at DNA replication forks stalled by inter-strand cross-links. Nucleic Acids Res
37: 6400-6413
[Abstract]
[Full Text]
-
Ying, S., Myers, K., Bottomley, S., Helleday, T., Bryant, H. E.
(2009). BRCA2-dependent homologous recombination is required for repair of Arsenite-induced replication lesions in mammalian cells. Nucleic Acids Res
37: 5105-5113
[Abstract]
[Full Text]
-
Guirouilh-Barbat, J., Zhang, Y.-W., Pommier, Y.
(2009). Induction of glutathione-dependent DNA double-strand breaks by the novel anticancer drug brostallicin. Molecular Cancer Therapeutics
8: 1985-1994
[Abstract]
[Full Text]
-
Hu, Y., Lu, X., Zhou, G., Barnes, E. L., Luo, G.
(2009). Recql5 Plays an Important Role in DNA Replication and Cell Survival after Camptothecin Treatment. Mol. Biol. Cell
20: 114-123
[Abstract]
[Full Text]
-
Rodriguez, R., Hansen, L. T., Phear, G., Scorah, J., Spang-Thomsen, M., Cox, A., Helleday, T., Meuth, M.
(2008). Thymidine Selectively Enhances Growth Suppressive Effects of Camptothecin/Irinotecan in MSI+ Cells and Tumors Containing a Mutation of MRE11. Clin. Cancer Res.
14: 5476-5483
[Abstract]
[Full Text]
-
Guirouilh-Barbat, J., Redon, C., Pommier, Y.
(2008). Transcription-coupled DNA Double-Strand Breaks Are Mediated via the Nucleotide Excision Repair and the Mre11-Rad50-Nbs1 Complex. Mol. Biol. Cell
19: 3969-3981
[Abstract]
[Full Text]
-
Derijck, A., van der Heijden, G., Giele, M., Philippens, M., de Boer, P.
(2008). DNA double-strand break repair in parental chromatin of mouse zygotes, the first cell cycle as an origin of de novo mutation. Hum Mol Genet
17: 1922-1937
[Abstract]
[Full Text]
-
Nomura, Y., Adachi, N., Koyama, H.
(2007). Human Mus81 and FANCB independently contribute to repair of DNA damage during replication. GENES CELLS
12: 1111-1122
[Abstract]
[Full Text]
-
Frohlich, R. F., Veigaard, C., Andersen, F. F., McClendon, A. K., Gentry, A. C., Andersen, A. H., Osheroff, N., Stevnsner, T., Knudsen, B. R.
(2007). Tryptophane-205 of human topoisomerase I is essential for camptothecin inhibition of negative but not positive supercoil removal. Nucleic Acids Res
35: 6170-6180
[Abstract]
[Full Text]
-
Seiler, J. A., Conti, C., Syed, A., Aladjem, M. I., Pommier, Y.
(2007). The Intra-S-Phase Checkpoint Affects both DNA Replication Initiation and Elongation: Single-Cell and -DNA Fiber Analyses. Mol. Cell. Biol.
27: 5806-5818
[Abstract]
[Full Text]
-
Lansiaux, A., Leonce, S., Kraus-Berthier, L., Bal-Mahieu, C., Mazinghien, R., Didier, S., David-Cordonnier, M.-H., Hautefaye, P., Lavielle, G., Bailly, C., Hickman, J. A., Pierre, A.
(2007). Novel Stable Camptothecin Derivatives Replacing the E-Ring Lactone by a Ketone Function Are Potent Inhibitors of Topoisomerase I and Promising Antitumor Drugs. Mol. Pharmacol.
72: 311-319
[Abstract]
[Full Text]
-
Kohzaki, M., Hatanaka, A., Sonoda, E., Yamazoe, M., Kikuchi, K., Vu Trung, N., Szuts, D., Sale, J. E., Shinagawa, H., Watanabe, M., Takeda, S.
(2007). Cooperative Roles of Vertebrate Fbh1 and Blm DNA Helicases in Avoidance of Crossovers during Recombination Initiated by Replication Fork Collapse. Mol. Cell. Biol.
27: 2812-2820
[Abstract]
[Full Text]
-
Takemura, H., Rao, V. A., Sordet, O., Furuta, T., Miao, Z.-H., Meng, L., Zhang, H., Pommier, Y.
(2006). Defective Mre11-dependent Activation of Chk2 by Ataxia Telangiectasia Mutated in Colorectal Carcinoma Cells in Response to Replication-dependent DNA Double Strand Breaks. J. Biol. Chem.
281: 30814-30823
[Abstract]
[Full Text]
-
Leonce, S., Kraus-Berthier, L., Golsteyn, R. M., David-Cordonnier, M.-H., Tardy, C., Lansiaux, A., Poindessous, V., Larsen, A. K., Pierre, A.
(2006). Generation of replication-dependent double-strand breaks by the novel n2-g-alkylator s23906-1.. Cancer Res.
66: 7203-7210
[Abstract]
[Full Text]
-
El-Khamisy, S. F., Caldecott, K. W.
(2006). TDP1-dependent DNA single-strand break repair and neurodegeneration. Mutagenesis
21: 219-224
[Abstract]
[Full Text]
-
Bryant, H. E., Helleday, T.
(2006). Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair. Nucleic Acids Res
34: 1685-1691
[Abstract]
[Full Text]
-
Pond, C. D., Marshall, K. M., Barrows, L. R.
(2006). Identification of a small topoisomerase I-binding peptide that has synergistic antitumor activity with 9-aminocamptothecin.. Molecular Cancer Therapeutics
5: 739-745
[Abstract]
[Full Text]
-
Baumann, C., Boehden, G. S., Burkle, A., Wiesmuller, L.
(2006). Poly(ADP-RIBOSE) polymerase-1 (Parp-1) antagonizes topoisomerase I-dependent recombination stimulation by P53. Nucleic Acids Res
34: 1036-1049
[Abstract]
[Full Text]
-
Marchand, C., Antony, S., Kohn, K. W., Cushman, M., Ioanoviciu, A., Staker, B. L., Burgin, A. B., Stewart, L., Pommier, Y.
(2006). A novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complex.. Molecular Cancer Therapeutics
5: 287-295
[Abstract]
[Full Text]
-
Rao, V. A., Fan, A. M., Meng, L., Doe, C. F., North, P. S., Hickson, I. D., Pommier, Y.
(2005). Phosphorylation of BLM, Dissociation from Topoisomerase III{alpha}, and Colocalization with {gamma}-H2AX after Topoisomerase I-Induced Replication Damage. Mol. Cell. Biol.
25: 8925-8937
[Abstract]
[Full Text]
-
Dendouga, N., Gao, H., Moechars, D., Janicot, M., Vialard, J., McGowan, C. H.
(2005). Disruption of Murine Mus81 Increases Genomic Instability and DNA Damage Sensitivity but Does Not Promote Tumorigenesis. Mol. Cell. Biol.
25: 7569-7579
[Abstract]
[Full Text]
-
Saleh-Gohari, N., Bryant, H. E., Schultz, N., Parker, K. M., Cassel, T. N., Helleday, T.
(2005). Spontaneous Homologous Recombination Is Induced by Collapsed Replication Forks That Are Caused by Endogenous DNA Single-Strand Breaks. Mol. Cell. Biol.
25: 7158-7169
[Abstract]
[Full Text]
-
Tu, L. C., Matsui, S. i., Beerman, T. A.
(2005). Hedamycin, a DNA alkylator, induces {gamma}H2AX and chromosome aberrations: Involvement of phosphatidylinositol 3-kinase-related kinases and DNA replication fork movement. Molecular Cancer Therapeutics
4: 1175-1185
[Abstract]
[Full Text]
-
Yu, D., Khan, E., Khaleque, M. A., Lee, J., Laco, G., Kohlhagen, G., Kharbanda, S., Cheng, Y.-C., Pommier, Y., Bharti, A.
(2004). Phosphorylation of DNA Topoisomerase I by the c-Abl Tyrosine Kinase Confers Camptothecin Sensitivity. J. Biol. Chem.
279: 51851-51861
[Abstract]
[Full Text]
-
Ferrara, L., Kmiec, E. B.
(2004). Camptothecin enhances the frequency of oligonucleotide-directed gene repair in mammalian cells by inducing DNA damage and activating homologous recombination. Nucleic Acids Res
32: 5239-5248
[Abstract]
[Full Text]
-
Adachi, N., So, S., Koyama, H.
(2004). Loss of Nonhomologous End Joining Confers Camptothecin Resistance in DT40 Cells: IMPLICATIONS FOR THE REPAIR OF TOPOISOMERASE I-MEDIATED DNA DAMAGE. J. Biol. Chem.
279: 37343-37348
[Abstract]
[Full Text]
-
Mross, K., Richly, H., Schleucher, N., Korfee, S., Tewes, M., Scheulen, M. E., Seeber, S., Beinert, T., Schweigert, M., Sauer, U., Unger, C., Behringer, D., Brendel, E., Haase, C. G., Voliotis, D., Strumberg, D.
(2004). A phase I clinical and pharmacokinetic study of the camptothecin glycoconjugate, BAY 38-3441, as a daily infusion in patients with advanced solid tumors. Ann Oncol
15: 1284-1294
[Abstract]
[Full Text]
-
Christensen, M. O., Krokowski, R. M., Barthelmes, H. U., Hock, R., Boege, F., Mielke, C.
(2004). Distinct Effects of Topoisomerase I and RNA Polymerase I Inhibitors Suggest a Dual Mechanism of Nucleolar/Nucleoplasmic Partitioning of Topoisomerase I. J. Biol. Chem.
279: 21873-21882
[Abstract]
[Full Text]
-
van Waardenburg, R. C.A.M., de Jong, L. A., van Delft, F., van Eijndhoven, M. A.J., Bohlander, M., Bjornsti, M.-A., Brouwer, J., Schellens, J. H.M.
(2004). Homologous recombination is a highly conserved determinant of the synergistic cytotoxicity between cisplatin and DNA topoisomerase I poisons. Molecular Cancer Therapeutics
3: 393-402
[Abstract]
[Full Text]
-
Block, W. D., Yu, Y., Lees-Miller, S. P.
(2004). Phosphatidyl inositol 3-kinase-like serine/threonine protein kinases (PIKKs) are required for DNA damage-induced phosphorylation of the 32 kDa subunit of replication protein A at threonine 21. Nucleic Acids Res
32: 997-1005
[Abstract]
[Full Text]
-
Mohindra, A., Bolderson, E., Stone, J., Wells, M., Helleday, T., Meuth, M.
(2004). A tumour-derived mutant allele of XRCC2 preferentially suppresses homologous recombination at DNA replication forks. Hum Mol Genet
13: 203-212
[Abstract]
[Full Text]
-
Bosco, E. E., Mayhew, C. N., Hennigan, R. F., Sage, J., Jacks, T., Knudsen, E. S.
(2004). RB signaling prevents replication-dependent DNA double-strand breaks following genotoxic insult. Nucleic Acids Res
32: 25-34
[Abstract]
[Full Text]
-
Kashishian, A., Douangpanya, H., Clark, D., Schlachter, S. T., Eary, C. T., Schiro, J. G., Huang, H., Burgess, L. E., Kesicki, E. A., Halbrook, J.
(2003). DNA-dependent protein kinase inhibitors as drug candidates for the treatment of cancer. Molecular Cancer Therapeutics
2: 1257-1264
[Abstract]
[Full Text]
-
Furuta, T., Takemura, H., Liao, Z.-Y., Aune, G. J., Redon, C., Sedelnikova, O. A., Pilch, D. R., Rogakou, E. P., Celeste, A., Chen, H. T., Nussenzweig, A., Aladjem, M. I., Bonner, W. M., Pommier, Y.
(2003). Phosphorylation of Histone H2AX and Activation of Mre11, Rad50, and Nbs1 in Response to Replication-dependent DNA Double-strand Breaks Induced by Mammalian DNA Topoisomerase I Cleavage Complexes. J. Biol. Chem.
278: 20303-20312
[Abstract]
[Full Text]
-
Hinz, J. M., Helleday, T., Meuth, M.
(2003). Reduced apoptotic response to camptothecin in CHO cells deficient in XRCC3. Carcinogenesis
24: 249-253
[Abstract]
[Full Text]
-
Liu, J.-S., Kuo, S.-R., Beerman, T. A., Melendy, T.
(2003). Induction of DNA Damage Responses by Adozelesin Is S Phase-specific and Dependent on Active Replication Forks. Molecular Cancer Therapeutics
2: 41-47
[Abstract]
[Full Text]
-
Vance, J. R., Wilson, T. E.
(2002). Yeast Tdp1 and Rad1-Rad10 function as redundant pathways for repairing Top1 replicative damage. Proc. Natl. Acad. Sci. USA
99: 13669-13674
[Abstract]
[Full Text]
-
Doe, C. L., Ahn, J. S., Dixon, J., Whitby, M. C.
(2002). Mus81-Eme1 and Rqh1 Involvement in Processing Stalled and Collapsed Replication Forks. J. Biol. Chem.
277: 32753-32759
[Abstract]
[Full Text]
-
Rapisarda, A., Uranchimeg, B., Scudiero, D. A., Selby, M., Sausville, E. A., Shoemaker, R. H., Melillo, G.
(2002). Identification of Small Molecule Inhibitors of Hypoxia-inducible Factor 1 Transcriptional Activation Pathway. Cancer Res.
62: 4316-4324
[Abstract]
[Full Text]
-
El-Hizawi, S., Lagowski, J. P., Kulesz-Martin, M., Albor, A.
(2002). Induction of Gene Amplification as a Gain-of-Function Phenotype of Mutant p53 Proteins. Cancer Res.
62: 3264-3270
[Abstract]
[Full Text]
-
Debethune, L., Kohlhagen, G., Grandas, A., Pommier, Y.
(2002). Processing of nucleopeptides mimicking the topoisomerase I-DNA covalent complex by tyrosyl-DNA phosphodiesterase. Nucleic Acids Res
30: 1198-1204
[Abstract]
[Full Text]
-
Zhou, Y., Gwadry, F. G., Reinhold, W. C., Miller, L. D., Smith, L. H., Scherf, U., Liu, E. T., Kohn, K. W., Pommier, Y., Weinstein, J. N.
(2002). Transcriptional Regulation of Mitotic Genes by Camptothecin-induced DNA Damage: Microarray Analysis of Dose- and Time-dependent Effects. Cancer Res.
62: 1688-1695
[Abstract]
[Full Text]
-
Meijer, M., Karimi-Busheri, F., Huang, T. Y., Weinfeld, M., Young, D.
(2002). Pnk1, a DNA Kinase/Phosphatase Required for Normal Response to DNA Damage by gamma -Radiation or Camptothecin in Schizosaccharomyces pombe. J. Biol. Chem.
277: 4050-4055
[Abstract]
[Full Text]
-
Urasaki, Y., Laco, G. S., Pourquier, P., Takebayashi, Y., Kohlhagen, G., Gioffre, C., Zhang, H., Chatterjee, D., Pantazis, P., Pommier, Y.
(2001). Characterization of a Novel Topoisomerase I Mutation from a Camptothecin-resistant Human Prostate Cancer Cell Line. Cancer Res.
61: 1964-1969
[Abstract]
[Full Text]
-
Arnaudeau, C., Rozier, L., Cazaux, C., Defais, M., Jenssen, D., Helleday, T.
(2001). RAD51 supports spontaneous non-homologous recombination in mammalian cells, but not the corresponding process induced by topoisomerase inhibitors. Nucleic Acids Res
29: 662-667
[Abstract]
[Full Text]
-
Pourquier, P., Waltman, J. L., Urasaki, Y., Loktionova, N. A., Pegg, A. E., Nitiss, J. L., Pommier, Y.
(2001). Topoisomerase I-mediated Cytotoxicity of N-Methyl-N'-nitro-N-nitrosoguanidine: Trapping of Topoisomerase I by the O6-Methylguanine. Cancer Res.
61: 53-58
[Abstract]
[Full Text]
-
Urasaki, Y., Laco, G., Takebayashi, Y., Bailly, C., Kohlhagen, G., Pommier, Y.
(2001). Use of Camptothecin-resistant Mammalian Cell Lines to Evaluate the Role of Topoisomerase I in the Antiproliferative Activity of the Indolocarbazole, NB-506, and Its Topoisomerase I Binding Site. Cancer Res.
61: 504-508
[Abstract]
[Full Text]